UPDATED Sep 08, 2025
Discover small cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
STABL | SEK 0.34 | -12.2% | -57.2% | SEK 21.8m | n/a | PB2.2x | n/a | n/a | ||
ATXI | US$0.73 | 28.4% | -75.7% | US$2.3m | n/a | PE0.9x | n/a | n/a | ||
HEAL | CA$0.09 | 5.9% | 80.0% | CA$3.2m | n/a | PB51.8x | n/a | n/a | ||
THC | CA$0.02 | 0% | -50.0% | CA$3.3m | n/a | PS1.5x | n/a | n/a | ||
SUNREST | ₹49.10 | -0.2% | -13.5% | ₹210.3m | n/a | PE10.5x | n/a | n/a | ||
SLRX | US$4.65 | -19.3% | -79.5% | US$2.4m | n/a | PE-0.5x | n/a | n/a | ||
RTGC | US$0.36 | 0% | -39.0% | US$2.4m | n/a | n/a | n/a | n/a | ||
EDXC | US$0.0041 | -3.3% | -68.5% | US$2.4m | n/a | n/a | n/a | n/a | ||
WINT | US$0.074 | -22.2% | -100.0% | US$2.5m | US$4.00 | PB0.7x | n/a | n/a | ||
AKAN | US$3.35 | -8.5% | -51.3% | US$2.5m | n/a | PS2.9x | n/a | n/a | ||
524400 | ₹75.25 | 0.3% | -4.7% | ₹223.2m | n/a | PE22x | n/a | n/a | ||
523620 | ₹33.46 | 8.4% | -40.1% | ₹223.4m | n/a | PB2.6x | n/a | n/a | ||
LEVBIO | SEK 0.34 | -5.0% | 14.4% | SEK 23.8m | n/a | PB12.4x | n/a | n/a | ||
VBS | AU$0.073 | -16.1% | -8.8% | AU$3.9m | n/a | PS8.1x | n/a | n/a | ||
NFX | UK£0.00095 | 0% | -35.6% | UK£1.9m | n/a | PB2.3x | n/a | n/a | ||
BIT | AU$0.003 | 0% | -81.3% | AU$4.0m | n/a | PS2.2x | n/a | n/a | ||
1AD | AU$0.0035 | -12.5% | -82.5% | AU$4.0m | n/a | PS6x | n/a | n/a | ||
991 | €0.98 | 0% | 228.3% | €2.3m | n/a | n/a | n/a | n/a | ||
530665 | ₹4.31 | 1.9% | -29.8% | ₹237.5m | n/a | PS1.9x | n/a | n/a | ||
PTIX | US$2.85 | -20.8% | n/a | US$2.7m | n/a | n/a | n/a | n/a | ||
LIPO | US$0.59 | -0.5% | -81.8% | US$2.8m | n/a | PS5.8x | n/a | n/a | ||
CTTH | US$0.04 | -16.1% | -39.4% | US$2.8m | n/a | n/a | n/a | n/a | ||
BOD | AU$0.024 | 0% | -65.2% | AU$4.3m | n/a | PS1.3x | n/a | n/a | ||
NMTR | US$0.20 | -71.1% | -96.0% | US$2.8m | US$9.58 | PE-0.06x | E41.4% | n/a |